anti-Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) 抗体产品概述

Full name:
anti-Non-Muscle Myosin Heavy Polypeptide 9 抗体 (MYH9)
在www.antibodies-online.cn可供108 Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) 抗体的17不同的供货商。 再加上,我们可以发Non-Muscle Myosin Heavy Polypeptide 9 试剂盒 (20)Non-Muscle Myosin Heavy Polypeptide 9 蛋白 (7)和数多这个蛋白质的别的产品。 总共142 Non-Muscle Myosin Heavy Polypeptide 9产品已列进来了。
别名:
BDPLT6, C80049, D0Jmb2, dfna17, E030044M24Rik, epsts, fi22c04, Fltn, ftns, KLG/PTK7, MHA, myh9, myh9l2, Myhn-1, Myhn1, myosin, nmhc-ii-a, NMHC II-A, NMHCIIA, NMMHC, NMMHC-A, NMMHC-IIA, nmmhca, NMMHC II-a, non-muscle, nonmuscle, TU72.6, wu:fi22c04, wu:fj85e11, zgc:66164, zgc:162029

最受欢迎的抗anti-Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) 抗体

选择您的来源和应用

抗Human 抗体:

抗Rat (Rattus) 抗体:

抗Mouse (Murine) 抗体:

所有可销售的anti-Non-Muscle Myosin Heavy Polypeptide 9 抗体

您会转到已过滤好的搜索

引用最多的anti-Non-Muscle Myosin Heavy Polypeptide 9 抗体

  1. Dog (Canine) Polyclonal MYH9 Primary Antibody for WB - ABIN2783216 : Sabbir, Dillon, Mowat: Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation. in Biology open 2016 (PubMed)

  2. Dog (Canine) Polyclonal MYH9 Primary Antibody for ICC, IF - ABIN153126 : Klingner, Cherian, Fels, Diesinger, Aufschnaiter, Maghelli, Keil, Beck, Tolić-Nørrelykke, Bathe, Wedlich-Soldner: Isotropic actomyosin dynamics promote organization of the apical cell cortex in epithelial cells. in The Journal of cell biology 2014 (PubMed)

更多抗Non-Muscle Myosin Heavy Polypeptide 9的相互作用对抗体

Human Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. Heterozygous deletional mutation (c.5803delG) in exon 41 of the MYH9 gene is associated with inherited thrombocytopenia.

  2. cytokinesis failure in megakaryocytes is the consequence of both the absence of NMIIB and a low RhoA activity that impairs NMIIA localization at the cleavage furrow through increased actin turnover.

  3. The loss of junctional NMIIA, upon Coronin 1B (显示 CORO1B 抗体) knockdown, perturbed RhoA (显示 RHOA 抗体) signaling.

  4. Results identified nonsynonymous variants in MYH9 and ABCA4 (显示 ABCA4 抗体) to be the most frequent risk loci in nonsyndromic orofacial clefts in the Taiwanese population.

  5. Our study is the first to identify genetic predisposition to transplant renal artery stenosis in patients with MYH9 risk allelic variants (rs4821480, rs4821481, rs3752462, rs11089788, rs136211, rs5756168, rs2032487, and rs2239784)

  6. The hearing impairment associated with MYH9 disorder in this family was characterized as adult onset, progressive, and high-frequency dominant. Hematological manifestations of MYH9 disorder show complete penetrance, whereas extra-hematological manifestations show incomplete penetrance and variable expressivity in this family.

  7. mass spectrum followed by immunoprecipitation identified non-muscle myosin heavy chain-IIA (NMMHC-IIA) as the CXCR4 (显示 CXCR4 抗体)-interacting protein. Furthermore, pharmaceutical inhibition of NMMHC-IIA by blebbistatin dampened the nuclear translocation of CXCR4 (显示 CXCR4 抗体) as well as the metastatic capacity of RCC (显示 XRCC1 抗体) cells

  8. The rs3752462 polymorphism of MYH9 is associated with high systolic blood pressure in patients with CKD. The T allele in the dominant model was associated with an elevated risk for high systolic blood pressure .

  9. The Raf (显示 RAF1 抗体)-ERK1/2 (显示 MAPK1/3 抗体) signaling pathway is involved in regulation of NMIIA by DT-13.

  10. HhnRNP-K-mediated regulation of NMHC IIA mRNA translation contributes to the control of enucleation in erythropoiesis.

Xenopus laevis Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. Data show that the locomotion and blebbing of the primordial germ cells (PGCs) required F-actin, myosin II activity and RhoA/Rho-associated protein kinase (ROCK) signaling.

Mouse (Murine) Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. Data show that deletion of myosin heavy chain II-A (Myh9)/myosin heavy chain II-B (Myh10 (显示 MYH10 抗体)) caused severe hydroureter/hydronephrosis at birth.

  2. our data indicated that PGDHC is a Pg-derived, cell-permeable ceramide that possesses a unique property of promoting osteoclastogenesis via interaction with Myh9 which, in turn, activates a Rac1/DC-STAMP (显示 TM7SF4 抗体) pathway for upregulation of osteoclast cell fusion.

  3. Conditional deletion of nonmuscle myosin II-A in mouse tongue epithelium results in squamous cell carcinoma

  4. Inhibition of NMMHC IIA impedes TF expression and venous thrombosis via Akt (显示 AKT1 抗体)/GSK3beta (显示 GSK3b 抗体)-NF-kappaB (显示 NFKB1 抗体) signalling pathways in the endothelium both in vitro and in vivo.

  5. Myh9 mediates colitis-induced epithelium injury by restricting Lgr5 (显示 LGR5 抗体)+ stem cells

  6. Mst1 (显示 MST1 抗体) regulates Myosin IIa dynamics to organize high and low affinity LFA-1 (显示 ITGAL 抗体) to the anterior and posterior membrane during T cell migration.

  7. DDR1 malfunction causes outer hair cells deformation and the separation of the lateral wall, the location of the cellular motor responsible for the electromotile property, explicitly in those regions showing DDR1 and NM-IIA co-localization.

  8. A new role for Arl13b (显示 ARL13B 抗体) in actin cytoskeleton remodeling through the interaction with Myh9.

  9. Lgl1 (显示 Klra7 抗体) forms two distinct complexes in vivo, Lgl1 (显示 Klra7 抗体)-NMIIA and Lgl1 (显示 Klra7 抗体)-Par6alpha (显示 PARD6A 抗体)-aPKCzeta (显示 PRKCZ 抗体), and that the formation of these complexes is affected by the phosphorylation state of Lgl1 (显示 Klra7 抗体).

  10. While MyoIIA activity is required for F-actin localization at the plasma membrane, it alone is insufficient to localize F-actin to the plasma membrane.

Zebrafish Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. Results demonstrate an important role of NMHC-IIA for the proper formation and function of the glomerulus in zebrafish.

Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) 抗原简介

Antigen Summary

This gene encodes a conventional non-muscle myosin\; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.

Alternative names and synonyms associated with Non-Muscle Myosin Heavy Polypeptide 9 (MYH9)

  • myosin, heavy chain 9, non-muscle (MYH9) 抗体
  • myosin, heavy chain 9, non-muscle (Myh9) 抗体
  • myosin, heavy chain 9, non-muscle (myh9) 抗体
  • myosin, heavy polypeptide 9, non-muscle (Myh9) 抗体
  • myosin, heavy polypeptide 9a, non-muscle (myh9a) 抗体
  • BDPLT6 抗体
  • C80049 抗体
  • D0Jmb2 抗体
  • dfna17 抗体
  • E030044M24Rik 抗体
  • epsts 抗体
  • fi22c04 抗体
  • Fltn 抗体
  • ftns 抗体
  • KLG/PTK7 抗体
  • MHA 抗体
  • myh9 抗体
  • myh9l2 抗体
  • Myhn-1 抗体
  • Myhn1 抗体
  • myosin 抗体
  • nmhc-ii-a 抗体
  • NMHC II-A 抗体
  • NMHCIIA 抗体
  • NMMHC 抗体
  • NMMHC-A 抗体
  • NMMHC-IIA 抗体
  • nmmhca 抗体
  • NMMHC II-a 抗体
  • non-muscle 抗体
  • nonmuscle 抗体
  • TU72.6 抗体
  • wu:fi22c04 抗体
  • wu:fj85e11 抗体
  • zgc:66164 抗体
  • zgc:162029 抗体

Protein level used designations for MYH9

cellular myosin heavy chain, type A , myosin heavy chain 9 , myosin heavy chain, non-muscle IIa , myosin-9 , non-muscle myosin heavy chain A , non-muscle myosin heavy chain IIa , non-muscle myosin heavy polypeptide 9 , nonmuscle myosin heavy chain II-A , NMMHC II-a , NMMHC-IIA , myosin, heavy polypeptide 9, non-muscle , NMMHC-A , nonmuscle myosin heavy chain-A , heavy polypeptide 9 , myosin heavy chain, nonmuscle , non-muscle IIa , type A , nonmuscle myosin II heavy chain A , flectin , myosin IIA , myosin heavy chain IX , fj85e11 , myosin, heavy chain 9, non-muscle, like-2 , zNMHC-IIA

GENE ID SPECIES
4627 Homo sapiens
481280 Canis lupus familiaris
25745 Rattus norvegicus
396469 Gallus gallus
398083 Xenopus laevis
404108 Bos taurus
100718592 Cavia porcellus
17886 Mus musculus
333938 Danio rerio
anti-Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) 抗体 精选生产商
您还需要查找其他产品吗?